» Articles » PMID: 36528448

Building and Sustaining Public and Political Commitment to the Value of Vaccination: Recommendations for the Immunization Agenda 2030 (Strategic Priority Area 2)

Abstract

Vaccines have contributed to substantial improvements in health and social development outcomes for millions in recent decades. However, equitable access to immunization remains a critical challenge that has stalled progress toward improving several health indicators around the world. The COVID-19 pandemic has also negatively impacted routine immunization services around the world further threatening universal access to the benefits of lifesaving vaccines. To overcome these challenges, the Immunization Agenda 2030 (IA2030) focuses on increasing both commitment and demand for vaccines. There are three broad barriers that will need to be addressed in order to achieve national and subnational immunization targets: (1) shifting leadership priorities and resource constraints, (2) visibility of disease burden, and (3) social and behavioral drivers. IA2030 proposes a set of interventions to address these barriers. First, efforts to ensure government engagement on immunization financing, regulatory, and legislative frameworks. Next, those in subnational leadership positions and local community members need to be further engaged to ensure local commitment and demand. Governance structures and health agencies must accept responsibility and be held accountable for delivering inclusive, quality, and accessible services and for achieving national targets. Further, the availability of quality immunization services and commitment to adequate financing and resourcing must go hand-in-hand with public health programs to increase access to and demand for vaccination. Last, strengthening trust in immunization systems and improving individual and program resilience can help mitigate the risk of vaccine confidence crises. These interventions together can help ensure a world where everyone, everywhere has access to and uses vaccines for lifesaving vaccination.

Citing Articles

Community members' knowledge, attitude, and practices towards Ebola virus prevention in the Western Province of Rwanda.

Umulisa M, Uwizera A, Ezeanochie N, Noben J, Indoe E, Kayumba M J Health Popul Nutr. 2025; 44(1):65.

PMID: 40045430 PMC: 11884175. DOI: 10.1186/s41043-025-00741-5.


COVID-19 Vaccination in the WHO African Region: Progress Made in 2022 and Factors Associated.

Mboussou F, Farham B, Nsasiirwe S, Atagbaza A, Oyaole D, Atuhebwe P Vaccines (Basel). 2023; 11(5).

PMID: 37243114 PMC: 10223522. DOI: 10.3390/vaccines11051010.


Reaching late adopters: factors influencing COVID-19 vaccination of Marshallese and Hispanic adults.

Vincenzo J, Spear M, Moore R, Purvis R, Patton S, Callaghan-Koru J BMC Public Health. 2023; 23(1):631.

PMID: 37013523 PMC: 10068695. DOI: 10.1186/s12889-023-15468-3.


Comparing Multivariate with Wealth-Based Inequity in Vaccination Coverage in 56 Countries: Toward a Better Measure of Equity in Vaccination Coverage.

Patenaude B, Sriudomporn S, Odihi D, Mak J, de Broucker G Vaccines (Basel). 2023; 11(3).

PMID: 36992121 PMC: 10057659. DOI: 10.3390/vaccines11030536.

References
1.
Rodriguez D, Whiteside A, Bennett S . Political commitment for vulnerable populations during donor transition. Bull World Health Organ. 2017; 95(2):121-127. PMC: 5327941. DOI: 10.2471/BLT.16.179861. View

2.
Khaleghian P . Decentralization and public services: the case of immunization. Soc Sci Med. 2004; 59(1):163-83. DOI: 10.1016/j.socscimed.2003.10.013. View

3.
Trumbo S, Silver D, Domenti O, Gasoyan H, Paatashvili E, Gellin B . Strengthening legal frameworks for vaccination: The experiences of Armenia, Georgia, and Moldova. Vaccine. 2018; 37(35):4840-4847. DOI: 10.1016/j.vaccine.2018.10.069. View

4.
Restrepo-Mendez M, Barros A, Wong K, Johnson H, Pariyo G, Wehrmeister F . Missed opportunities in full immunization coverage: findings from low- and lower-middle-income countries. Glob Health Action. 2016; 9:30963. PMC: 4856841. DOI: 10.3402/gha.v9.30963. View

5.
ODriscoll M, Ribeiro Dos Santos G, Wang L, Cummings D, Azman A, Paireau J . Age-specific mortality and immunity patterns of SARS-CoV-2. Nature. 2020; 590(7844):140-145. DOI: 10.1038/s41586-020-2918-0. View